Cytometry Part B: Clinical Cytometry最新文献

筛选
英文 中文
An unusual pattern observed upon the addition of CD79b to a flow cytometry B-cell lymphoma panel. 在流式细胞术b细胞淋巴瘤面板上添加CD79b后观察到一种不寻常的模式。
IF 2.3 3区 医学
Cytometry Part B: Clinical Cytometry Pub Date : 2025-07-14 DOI: 10.1002/cyto.b.22246
Vandana Panakkal, Raniah Al Amri, Stacey Mamatas, Wendy Shallenberger, Sara A Monaghan, Ahmad Al-Attar
{"title":"An unusual pattern observed upon the addition of CD79b to a flow cytometry B-cell lymphoma panel.","authors":"Vandana Panakkal, Raniah Al Amri, Stacey Mamatas, Wendy Shallenberger, Sara A Monaghan, Ahmad Al-Attar","doi":"10.1002/cyto.b.22246","DOIUrl":"https://doi.org/10.1002/cyto.b.22246","url":null,"abstract":"","PeriodicalId":10883,"journal":{"name":"Cytometry Part B: Clinical Cytometry","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2025-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144625560","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enhancing detection of central nervous system involvement in multiple myeloma: A novel multidimensional dot-plot based analysis for flow cytometry. 增强多发性骨髓瘤中枢神经系统受累的检测:一种新的基于流式细胞术的多维点图分析。
IF 2.3 3区 医学
Cytometry Part B: Clinical Cytometry Pub Date : 2025-07-07 DOI: 10.1002/cyto.b.22245
Bettina Palicskó, Luca Janovák, László Rejtő, László Váróczy, Zsuzsanna Hevessy, Bettina Kárai
{"title":"Enhancing detection of central nervous system involvement in multiple myeloma: A novel multidimensional dot-plot based analysis for flow cytometry.","authors":"Bettina Palicskó, Luca Janovák, László Rejtő, László Váróczy, Zsuzsanna Hevessy, Bettina Kárai","doi":"10.1002/cyto.b.22245","DOIUrl":"https://doi.org/10.1002/cyto.b.22245","url":null,"abstract":"<p><p>Central nervous system (CNS) involvement in multiple myeloma (MM) is a rare but severe complication with a poor prognosis. The identification of malignant plasma cells in cerebrospinal fluid (CSF) is essential for early diagnosis and intervention. However, the sensitivity of traditional diagnostic methods like cytology is low, especially in samples with low-cell counts. This study aimed to develop a multidimensional radar dot-plot analysis using Kaluza software to enhance the sensitivity and specificity of flow cytometry for detecting abnormal plasma cells in CSF. One hundred and twenty-five CSF samples were sent for flow cytometric testing to investigate the central nervous system involvement of MM. Finally, 89 samples from 40 patients were included in our study. Multicolor flow cytometry was performed using an 8-color labeling method, and radar dot-plot analysis was developed using diagnostic bone marrow samples to distinguish normal plasma cells, abnormal plasma cells, and cellular debris. The sensitivity of the novel method was evaluated by diluting myeloma bone marrow cells in pooled CSF samples to simulate low cell counts. Of the 125 CSF specimens, 16 samples from 4 patients showed abnormal plasma cells using both conventional and multidimensional flow cytometry analysis. Discordant results were found in 32 samples (25%), where conventional analysis suggested the presence of abnormal cells, but these were ruled out by multidimensional analysis. Sensitivity testing showed that the multidimensional dot-plot method outperforms conventional two-dimensional dot-plot analysis, as the radar dot plot can be used to identify abnormal cells in samples diluted to 5 WBC/μL, where the cell count of abnormal plasma cells is < 1 cell/μL. Our results showed that the new radar dot-plot analysis can increase the sensitivity and specificity of flow cytometry in MM for the detection of CNS involvement, even in low-cell-count CSF samples, regardless of whether the sample was obtained in a tube containing special reagent or not (TransFix/EDTA CSF Sample Storage tubes). This approach improves diagnostic accuracy, reduces the number of false positive cases caused by antibodies adhering to cell debris, and provides a reliable tool for assessing neurological complications in MM. Further validation is needed in a larger number of cases and testing of the method on different antibody panels.</p>","PeriodicalId":10883,"journal":{"name":"Cytometry Part B: Clinical Cytometry","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2025-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144575004","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An uncommon case of acute megakaryoblastic leukemia with DDX3X::MLLT10 fusion gene. 急性巨核细胞白血病合并DDX3X::MLLT10融合基因1例。
IF 2.3 3区 医学
Cytometry Part B: Clinical Cytometry Pub Date : 2025-07-04 DOI: 10.1002/cyto.b.22243
Ting Li, Ping Wu, Man Chen, Xiuyun Zhao, Aixian Wang, Hui Wang
{"title":"An uncommon case of acute megakaryoblastic leukemia with DDX3X::MLLT10 fusion gene.","authors":"Ting Li, Ping Wu, Man Chen, Xiuyun Zhao, Aixian Wang, Hui Wang","doi":"10.1002/cyto.b.22243","DOIUrl":"https://doi.org/10.1002/cyto.b.22243","url":null,"abstract":"","PeriodicalId":10883,"journal":{"name":"Cytometry Part B: Clinical Cytometry","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2025-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144559475","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A 20-color 21-antigen flow cytometric assay for disease monitoring of T-cell lymphoblastic leukemia. 一种用于t淋巴细胞白血病疾病监测的20色21抗原流式细胞术试验。
IF 2.3 3区 医学
Cytometry Part B: Clinical Cytometry Pub Date : 2025-07-03 DOI: 10.1002/cyto.b.22242
Qi Gao, Jingping Zhang, Krasimira Rozenova, Xiaotian Sun, Amanda Burke, Olivia Miu, Nghia Nguyen, Shu Jie Zhang, Mikhail Roshal
{"title":"A 20-color 21-antigen flow cytometric assay for disease monitoring of T-cell lymphoblastic leukemia.","authors":"Qi Gao, Jingping Zhang, Krasimira Rozenova, Xiaotian Sun, Amanda Burke, Olivia Miu, Nghia Nguyen, Shu Jie Zhang, Mikhail Roshal","doi":"10.1002/cyto.b.22242","DOIUrl":"https://doi.org/10.1002/cyto.b.22242","url":null,"abstract":"<p><p>T-lineage acute lymphoblastic leukemia (T-ALL) is an aggressive neoplasm of immature T cells. Flow cytometry plays a critical role in the diagnosis and management of the disease. It is used to establish the abnormal immature T-cell phenotype and to distinguish the early T-cell precursor (ETP)-ALL from more mature types at diagnosis. The evaluation of mediastinal disease is often complicated by the difficulty of the phenotypic distinction between the normal thymic precursors and the abnormal T lymphoblasts. Follow-up measurements of minimal/measurable residual disease (MRD) are critical for therapy decision-making and prognostication. In the MRD setting, flow cytometry requires a high degree of analytical expertise and assessment of numerous antigens. To address the diagnostic and monitoring challenges, we developed a single-tube 21-antigen assessment with simplified analysis. The assay distinguishes between normal thymic precursors and T lymphoblasts in tissue samples, enables evaluation of ETP versus non-ETP phenotypes, and allows for MRD assessment below 0.01% robust to antigenic changes.</p>","PeriodicalId":10883,"journal":{"name":"Cytometry Part B: Clinical Cytometry","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2025-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144552552","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Frequency and stability of populations of CD4+ and CD4+CD25+Foxp3+CD127lo Treg in healthy adults defined by cytometry using monoclonal antibodies to T cell associated molecules. 利用T细胞相关分子单克隆抗体测定健康成人CD4+和CD4+CD25+Foxp3+CD127lo Treg群体的频率和稳定性
IF 2.3 3区 医学
Cytometry Part B: Clinical Cytometry Pub Date : 2025-06-04 DOI: 10.1002/cyto.b.22241
Nirupama D Verma, Ranje Al-Atiyah, Prateek Rakesh, Andrew D Lam, Christopher Chiu, Giang T Tran, Bruce M Hall, Suzanne J Hodgkinson
{"title":"Frequency and stability of populations of CD4<sup>+</sup> and CD4<sup>+</sup>CD25<sup>+</sup>Foxp3<sup>+</sup>CD127<sup>lo</sup> Treg in healthy adults defined by cytometry using monoclonal antibodies to T cell associated molecules.","authors":"Nirupama D Verma, Ranje Al-Atiyah, Prateek Rakesh, Andrew D Lam, Christopher Chiu, Giang T Tran, Bruce M Hall, Suzanne J Hodgkinson","doi":"10.1002/cyto.b.22241","DOIUrl":"https://doi.org/10.1002/cyto.b.22241","url":null,"abstract":"<p><p>Monitoring subpopulations of CD4<sup>+</sup> T cells in blood, especially regulatory CD4<sup>+</sup>CD25<sup>+</sup>Foxp3<sup>+</sup>CD127<sup>lo</sup>T cells, has the potential to identify tolerance to transplants and defects that cause autoimmunity. CD45RA is expressed by naïve/resting CD4<sup>+</sup>, not by activated cells. Staining CD45RA with CD25 or Foxp3 identifies five populations of CD4<sup>+</sup> T cells, three Treg, and two CD4<sup>+</sup>Foxp3<sup>-</sup>T cells. CD25 is induced on activation of effector cells and is constitutively expressed by Treg. Examining Foxp3<sup>+</sup> cells in CD4<sup>+</sup>CD25<sup>+</sup>CD127<sup>lo</sup>, identified three Treg populations. It is not known how stable these populations of CD4<sup>+</sup>T cells are within individuals and between individuals. Repeated estimations over 3 years in 10 HV showed the proportion of cells in the three Treg populations was stable, whereas the two Foxp3<sup>-</sup> populations varied. In a larger cohort of 110 samples, females had higher numbers of CD4<sup>+</sup> cells than males. As a percentage of lymphocytes, there was no sex difference in the proportion of cells in the five populations. With age, there were fewer total Treg, with fewer resting Treg but an increase in activated Treg. Activation of both naïve CD4<sup>+</sup> T cells and Treg induces expression of chemokine receptors associated with Th1, Th17, and Th2 responses that promote their infiltration into sites of inflammation. Activated Treg expressed CCR4 and, in addition, expressed CXCR3 (Th1), CCR6 (Th17), or neither CXCR3 nor CCR6 (Th2). Some Treg expressed both CCR6 and CXCR3. HLA-DR and CD39 were expressed by activated Treg, and many cells expressed both. There was low PD-1 expression. The stability of the major Treg populations suggested it could be feasible to establish normal ranges for the three Treg populations. Staining for chemokine receptors and Treg effector molecules in activated Treg populations may detect changes in immune homeostasis and tolerance.</p>","PeriodicalId":10883,"journal":{"name":"Cytometry Part B: Clinical Cytometry","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2025-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144215202","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Issue highlights—June 2025 本期重点报道——2025年6月
IF 2.3 3区 医学
Cytometry Part B: Clinical Cytometry Pub Date : 2025-05-30 DOI: 10.1002/cyto.b.22239
Joseph A. DiGiuseppe
{"title":"Issue highlights—June 2025","authors":"Joseph A. DiGiuseppe","doi":"10.1002/cyto.b.22239","DOIUrl":"https://doi.org/10.1002/cyto.b.22239","url":null,"abstract":"","PeriodicalId":10883,"journal":{"name":"Cytometry Part B: Clinical Cytometry","volume":"108 3","pages":"195-197"},"PeriodicalIF":2.3,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144179068","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Remembering Dr. Bruce H. Davis: A passionate leader in clinical flow cytometry 纪念Bruce H. Davis博士:一位充满激情的临床流式细胞术领导者
IF 2.3 3区 医学
Cytometry Part B: Clinical Cytometry Pub Date : 2025-05-30 DOI: 10.1002/cyto.b.22240
{"title":"Remembering Dr. Bruce H. Davis: A passionate leader in clinical flow cytometry","authors":"","doi":"10.1002/cyto.b.22240","DOIUrl":"https://doi.org/10.1002/cyto.b.22240","url":null,"abstract":"","PeriodicalId":10883,"journal":{"name":"Cytometry Part B: Clinical Cytometry","volume":"108 3","pages":"189-194"},"PeriodicalIF":2.3,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144179067","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intraoperative flow cytometry in detecting free carcinoma cells in peritoneal lavage fluid of gastric carcinoma cases. 术中流式细胞术检测胃癌患者腹腔灌洗液中游离癌细胞。
IF 2.3 3区 医学
Cytometry Part B: Clinical Cytometry Pub Date : 2025-05-26 DOI: 10.1002/cyto.b.22238
Thulasi Raman Ramalingam, Bharaneedharan Marimuthu, Harsha N Rasheed, Archana Lakshmanan, Swetha Lakshmi Narla, Lakshman Vaidhyanathan, Ajit Pai
{"title":"Intraoperative flow cytometry in detecting free carcinoma cells in peritoneal lavage fluid of gastric carcinoma cases.","authors":"Thulasi Raman Ramalingam, Bharaneedharan Marimuthu, Harsha N Rasheed, Archana Lakshmanan, Swetha Lakshmi Narla, Lakshman Vaidhyanathan, Ajit Pai","doi":"10.1002/cyto.b.22238","DOIUrl":"https://doi.org/10.1002/cyto.b.22238","url":null,"abstract":"<p><p>The free carcinoma cells (FCC) in peritoneal lavage fluid are an independent adverse prognostic factor in patients with gastric carcinoma. Detection of FCC in the pre-operative peritoneal lavage fluid is critical, as patients with FCC do not have a survival advantage with curative cytoreductive (CCR) surgery. Cytology is currently used to assess FCC, but its sensitivity is poor and there is a need for better sensitive techniques. We attempted to study the efficiency of intra-operative flow cytometry (FCM) in detecting FCC in peritoneal lavage fluid of gastric carcinoma patients. In this prospective study, 32 peritoneal lavage fluids were analyzed intra-operatively by cytology and FCM. The median time taken for sample processing was 47 min. The concordance was achieved in 84% (27/32) of samples. FCM detected FCC in 17 peritoneal lavage fluids, of which only 12 were reported positive by cytology. Five cases that had a FCC burden of less than 0.01% were reported negative by cytology. FCC with programmed death-ligand 1 (PD-L1) expression of greater than 50% was noted in 12 cases. Intra-operative FCM improves the detection of FCC in peritoneal lavage fluid compared to cytology. Due to higher sensitivity, flow cytometry offers a promising adjuvant to cytology and helps in deciding on judicious radical CCR.</p>","PeriodicalId":10883,"journal":{"name":"Cytometry Part B: Clinical Cytometry","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2025-05-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144141761","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of monoclonal antibody to CD59 for the diagnosis of paroxysmal nocturnal hemoglobinuria by flow cytometry. 流式细胞术检测CD59单克隆抗体诊断阵发性夜间血红蛋白尿的比较。
IF 2.3 3区 医学
Cytometry Part B: Clinical Cytometry Pub Date : 2025-05-05 DOI: 10.1002/cyto.b.22237
Nikiforova Kseniya Alexandrovna, Kapranov Nikolai Mikhailovich, Davydova Yulia Olegovna, Fidarova Zalina Taymurazovna, Galtseva Irina Vladimirovna, Parovnichnikova Elena Nikolaevna
{"title":"Comparison of monoclonal antibody to CD59 for the diagnosis of paroxysmal nocturnal hemoglobinuria by flow cytometry.","authors":"Nikiforova Kseniya Alexandrovna, Kapranov Nikolai Mikhailovich, Davydova Yulia Olegovna, Fidarova Zalina Taymurazovna, Galtseva Irina Vladimirovna, Parovnichnikova Elena Nikolaevna","doi":"10.1002/cyto.b.22237","DOIUrl":"https://doi.org/10.1002/cyto.b.22237","url":null,"abstract":"","PeriodicalId":10883,"journal":{"name":"Cytometry Part B: Clinical Cytometry","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2025-05-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143994072","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Detection of circulating tumor cells is achieved by flow cytometry in melanoma patients. 通过流式细胞术检测黑色素瘤患者的循环肿瘤细胞。
IF 2.3 3区 医学
Cytometry Part B: Clinical Cytometry Pub Date : 2025-04-15 DOI: 10.1002/cyto.b.22236
Ludivine Fourdrain, Théo Brochet, Valentin Clichet, Guillaume Chaby, Brigitte Gubler, Loïc Garçon, Jean-Philippe Arnault, Thomas Boyer
{"title":"Detection of circulating tumor cells is achieved by flow cytometry in melanoma patients.","authors":"Ludivine Fourdrain, Théo Brochet, Valentin Clichet, Guillaume Chaby, Brigitte Gubler, Loïc Garçon, Jean-Philippe Arnault, Thomas Boyer","doi":"10.1002/cyto.b.22236","DOIUrl":"https://doi.org/10.1002/cyto.b.22236","url":null,"abstract":"<p><p>Melanoma is an aggressive skin tumor whose incidence is rising sharply, and for which the determination of new prognostic factors is a major challenge. In oncology, circulating tumor cells (CTCs) are at the heart of much research, as they represent a source of tumor material obtained non-invasively by liquid biopsy. With this in mind, this prospective, longitudinal study looked at the detection of CTCs in melanoma patients using the flow cytometry technique, and constitutes a proof-of-principle study, as molecular biology is the most widely used technique today to detect CTCs. The labeling strategy showed high sensitivity and specificity for melanoma cells. All 35 patients in the cohort presented at least one CTC at inclusion, demonstrating that the cells circulate regardless of the stage of the disease. However, a significant increase in the number of CTCs was observed in metastatic stages compared with non-metastatic stages. With regard to the main prognostic factors for melanoma, no significant association was found between the number of CTCs and Breslow thickness or the presence of ulceration. This study must be continued in order to increase the size of the sample, with a more consistent longitudinal follow-up, in order to gain a better understanding of the prognostic significance of CTCs.</p>","PeriodicalId":10883,"journal":{"name":"Cytometry Part B: Clinical Cytometry","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2025-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143994134","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信